Apollo Hospitals Enterprise (APOLLOHOSP) Share Price
NSE · Healthcare · Medical Care Facilities · ISIN INE437A01024
Key metrics
- Market Cap
- ₹1.11 L Cr
- P/E Ratio
- 53.01
- EPS
- 145.26
- Book Value
- 693.71
- P/B Ratio
- 11.36
- ROE
- 19.47%
- ROCE
- 15.72%
- Debt / Equity
- 0.85
- Net Margin
- 7.79%
- Revenue Growth
- 15.72%
- Profit Growth
- 34.29%
- Dividend Yield
- 0.25%
- 52W High
- ₹9,070.50
- 52W Low
- ₹6,696.50
- Market Cap Band
- large cap
- Face Value
- 5
Ratios computed from the annual results period ending 2026-03-31.
About Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent for life, general, and health insurance. In addition, it operates hospitals, pharmacies, primary care clinics, and diagnostic centers; short stay facilities, boutique birthing centers, multi-specialty clinics, dental and dialysis facilities, and preventive care; day surgery, diabetes management, and cradle and fertility centers; and Apollo 24/7, a digital health mobile platform that provides teleconsultations, online pharmacy deliveries, home diagnostics, and insurance services. Further, the company engages in the business of bio-banking of tissues. It serves patients, corporate clients, and the government and public sectors. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.
- Headquarters
- Chennai, India
- Employees
- 44,008
- Promoter Holding
- 28.39%
Apollo Hospitals Enterprise and the Medical Care Facilities industry
Apollo Hospitals Enterprise is one of 35 listed companies in the Medical Care Facilities industry. At a P/E of 53.0, it trades above the industry median of 45.8.
All Medical Care Facilities stocks →Healthcare sector stocks →
Related companies
- Manipal Health EnterprisesMANIPALHOS · ₹642.40₹82,875 Cr
- Max Healthcare InstituteMAXHEALTH · ₹848.05₹80,785 Cr
- Aster DM Quality CareASTERDM · ₹674.40₹58,154 Cr
- Fortis HealthcareFORTIS · ₹737.25₹55,701 Cr
- Narayana HrudayalayaNH · ₹1,719.40₹35,358 Cr
- Global HealthMEDANTA · ₹1,240.80₹33,270 Cr
- Krishna Institute of Medical SciencesKIMS · ₹679.45₹28,497 Cr
- Rainbow Children's MedicareRAINBOW · ₹1,245.30₹12,598 Cr
Apollo Hospitals Enterprise: key questions
What does Apollo Hospitals Enterprise do?
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments.
What is the share price of Apollo Hospitals Enterprise?
Apollo Hospitals Enterprise (APOLLOHOSP) last traded at ₹7,880.50 on the NSE, down 0.1% on the day. Over the past 52 weeks it has traded between ₹6,696.50 and ₹9,070.50. The current price is 13.1% below its 52-week high.
What is the market cap of Apollo Hospitals Enterprise?
Apollo Hospitals Enterprise has a market capitalisation of ₹1.11 L Cr, which makes it a large-cap company. It is the 1st largest of 35 listed companies in the Medical Care Facilities industry by market capitalisation.
What is the P/E ratio of Apollo Hospitals Enterprise?
Apollo Hospitals Enterprise trades at a price-to-earnings (P/E) ratio of 53.0. The median P/E across profitable companies in the Medical Care Facilities industry is 45.8.
What are Apollo Hospitals Enterprise's ROE and ROCE?
For the financial year ended March 2026, Apollo Hospitals Enterprise reported a return on equity (ROE) of 19.5%, a return on capital employed (ROCE) of 15.7% and a net profit margin of 7.8%.
How fast is Apollo Hospitals Enterprise growing?
In the financial year ended March 2026, Apollo Hospitals Enterprise's revenue grew 15.7% and net profit grew 34.3% compared with the previous year.
Does Apollo Hospitals Enterprise have debt?
Apollo Hospitals Enterprise has a debt-to-equity ratio of 0.85, meaning borrowings are about 85% of shareholders' equity.
Does Apollo Hospitals Enterprise pay a dividend?
Apollo Hospitals Enterprise has a dividend yield of 0.25% at the current share price.
What is the promoter holding in Apollo Hospitals Enterprise?
Promoters hold 28.4% of Apollo Hospitals Enterprise. Institutional investors hold 49.7%.
Which companies are similar to Apollo Hospitals Enterprise?
Listed companies close to Apollo Hospitals Enterprise in size within the Medical Care Facilities industry include Manipal Health Enterprises, Max Healthcare Institute, Aster DM Quality Care, Fortis Healthcare, Narayana Hrudayalaya and Global Health.
Figures are for information only and are not investment advice.
The full Apollo Hospitals Enterprise analysis
Create a free account to open the complete APOLLOHOSP deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.